Related Experiment Video
Updated: Jun 13, 2026

Bladder Smooth Muscle Strip Contractility as a Method to Evaluate Lower Urinary Tract Pharmacology
Published on: August 18, 2014
A comparative review of oxybutynin chloride formulations: pharmacokinetics and therapeutic efficacy in overactive
1McKay Department of Urology, Carolinas Medical Center Charlotte, NC.
Abstract:
Antimuscarinic agents remain the mainstay of treatment of overactive bladder. However, the utility of some of these agents is limited due to tolerability concerns, multiple daily dosage regimens, lack of formulary coverage, and high cost. This can lead to problems with long-term compliance and may preclude optimal management. Oxybutynin has been the most widely prescribed antimuscarinic agent for more than 30 years. To meet the needs of tolerability and compliance, oxybutynin has evolved from an immediate-release pill to a once-daily oral dose and is now available as a topical gel. This review compares the various oxybutynin formulations in terms of pharmacokinetics, efficacy, and tolerability issues.
Related Concept Videos
Cholinergic Antagonists: Pharmacokinetics
Urodynamic Studies: Uroflowmetry
Indirect-Acting Cholinergic Agonists: Pharmacokinetics
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they are...
Bioequivalence: Overview
Direct-Acting Cholinergic Agonists: Pharmacokinetics
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence